Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Shire takes on an ex-Cubist site
by Lisa M. Jarvis
March 21, 2016
| A version of this story appeared in
Volume 94, Issue 12
Shire has leased two of the three former Cubist Pharmaceuticals buildings in Lexington, Mass. Merck & Co. bought Cubist in early 2015 and subsequently shuttered early research at the antibiotics firm. That closure provided an opportunity for Shire, which according to an official has seen its headcount in Massachusetts grow by 700 people. “Given this growth, Shire continues to review our corporate, R&D, and manufacturing space needs,” the official says. Shire gained a research center in Cambridge, Mass., through its acquisition of Baxalta.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter